Status:
COMPLETED
Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study
Lead Sponsor:
AstraZeneca
Conditions:
GERD
Eligibility:
All Genders
17+ years
Brief Summary
To evaluate symptomatic outcome and HRQoL in GERD patients treated following a new CP Guideline.
Eligibility Criteria
Inclusion
- Signed informed consent
- Age above 18
- Subjects with typical GERD symptoms: predominant heartburn/regurgitation
- Naive patients or off PPI treatment in the last 2 months
Exclusion
- Inability to read and understand PRO instructions
- Patient not suitable to be treated following the AEG guidelines
- Concomitant treatment with NSAID, antiplatelet drugs
- Previous PPI failure
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00697008
Start Date
December 1 2007
Last Update
February 10 2009
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Badajoz, Badajoz, Spain
2
Research Site
Palma de Mallorca, Balearic Islands, Spain
3
Research Site
Barcelona, Barcelona, Spain
4
Research Site
Sabadell, Barcelona, Spain